Literature DB >> 31243955

Triggered Release Enhances the Cytotoxicity of Stable Colloidal Drug Aggregates.

Eric N Donders1,2, Ahil N Ganesh1,2, Hayarpi Torosyan3, Parnian Lak3, Brian K Shoichet3, Molly S Shoichet1,2,4.   

Abstract

Chemotherapeutics that self-assemble into colloids have limited efficacy above their critical aggregation concentration due to their inability to penetrate intact plasma membranes. Even when colloid uptake is promoted, issues with colloid escape from the endolysosomal pathway persist. By stabilizing acid-responsive lapatinib colloids through coaggregation with fulvestrant, and inclusion of transferrin, we demonstrate colloid internalization by cancer cells, where subsequent lapatinib ionization leads to endosomal leakage and increased cytotoxicity. These results demonstrate a strategy for triggered drug release from stable colloidal aggregates.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31243955      PMCID: PMC7136197          DOI: 10.1021/acschembio.9b00247

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  37 in total

1.  Identification and prediction of promiscuous aggregating inhibitors among known drugs.

Authors:  James Seidler; Susan L McGovern; Thompson N Doman; Brian K Shoichet
Journal:  J Med Chem       Date:  2003-10-09       Impact factor: 7.446

2.  Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.

Authors:  Brian Y Feng; Brian K Shoichet
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

3.  A New Spin on Antibody-Drug Conjugates: Trastuzumab-Fulvestrant Colloidal Drug Aggregates Target HER2-Positive Cells.

Authors:  Ahil N Ganesh; Christopher K McLaughlin; Da Duan; Brian K Shoichet; Molly S Shoichet
Journal:  ACS Appl Mater Interfaces       Date:  2017-03-28       Impact factor: 9.229

4.  Leveraging Colloidal Aggregation for Drug-Rich Nanoparticle Formulations.

Authors:  Ahil N Ganesh; Jennifer Logie; Christopher K McLaughlin; Benjamin L Barthel; Tad H Koch; Brian K Shoichet; Molly S Shoichet
Journal:  Mol Pharm       Date:  2017-05-19       Impact factor: 4.939

5.  A Decade of the Protein Corona.

Authors:  Pu Chun Ke; Sijie Lin; Wolfgang J Parak; Thomas P Davis; Frank Caruso
Journal:  ACS Nano       Date:  2017-12-05       Impact factor: 15.881

6.  Quantitative Mapping of the Spatial Distribution of Nanoparticles in Endo-Lysosomes by Local pH.

Authors:  Jing Wang; Sarah R MacEwan; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2017-01-03       Impact factor: 11.189

7.  The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH.

Authors:  Rikke V Benjaminsen; Maria A Mattebjerg; Jonas R Henriksen; S Moein Moghimi; Thomas L Andresen
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

8.  Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.

Authors:  Niraj S Trasi; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2015-06-08       Impact factor: 3.534

9.  Colloidal aggregation affects the efficacy of anticancer drugs in cell culture.

Authors:  Shawn C Owen; Allison K Doak; Pascal Wassam; Molly S Shoichet; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2012-06-08       Impact factor: 5.100

10.  Colloidal drug formulations can explain "bell-shaped" concentration-response curves.

Authors:  Shawn C Owen; Allison K Doak; Ahil N Ganesh; Lyudmila Nedyalkova; Christopher K McLaughlin; Brian K Shoichet; Molly S Shoichet
Journal:  ACS Chem Biol       Date:  2014-01-15       Impact factor: 5.100

View more
  2 in total

1.  A Crowding Barrier to Protein Inhibition in Colloidal Aggregates.

Authors:  Parnian Lak; Henry O'Donnell; Xuewen Du; Matthew P Jacobson; Brian K Shoichet
Journal:  J Med Chem       Date:  2021-03-24       Impact factor: 7.446

2.  Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase.

Authors:  Lennart Brewitz; Anthony Tumber; Xiaojin Zhang; Christopher J Schofield
Journal:  Bioorg Med Chem       Date:  2020-08-06       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.